These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results.
    Author: Milanese C, La Mantia L, Salmaggi A, Campi A, Bortolami C, Tajoli L, Nespolo A, Corridori F.
    Journal: Ital J Neurol Sci; 1988 Feb; 9(1):53-7. PubMed ID: 3281916.
    Abstract:
    The preliminary results of a double blind controlled prospective randomized trial of Azathioprine for therapeutic efficacy in 38 patients with Multiple Sclerosis are reported. Progression of the disease is significantly reduced in Azathioprine-treated group in comparison to Placebo-treated patients, but this effect is reached only after 3 years of treatment (P less than 0.025) regardless of the clinical course and without affecting relapse rate.
    [Abstract] [Full Text] [Related] [New Search]